Business news VIDEO: Grafa interview with Firebrick Pharma's Executive Chairman Dr Peter Molloy Written by Grafa| Grafa Published: 28 Apr 2022, 3:13 am UTC To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 videoVideo Player is loading.Play VideoPauseSkip BackwardSkip ForwardUnmuteCurrent Time 0:16/Duration 4:48Loaded: 22.17%0:16Stream Type LIVESeek to live, currently behind liveLIVERemaining Time -4:32 1xPlayback RateChaptersChaptersDescriptionsdescriptions off, selectedCaptionscaptions settings, opens captions settings dialogcaptions off, selectedAudio Trackdefault, selectedPicture-in-PictureFullscreenThis is a modal window.Beginning of dialog window. Escape will cancel and close the window.TextColorWhiteBlackRedGreenBlueYellowMagentaCyanOpacityOpaqueSemi-TransparentText BackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanOpacityOpaqueSemi-TransparentTransparentCaption Area BackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanOpacityTransparentSemi-TransparentOpaqueFont Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDrop shadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall CapsResetDoneClose Modal DialogEnd of dialog window.Share Facebook LinkedIn Twitter Email Copy link Firebrick Pharma's Executive Chairman Dr Peter Molloy speaks to Grafa?s Grady Wulff about the start of the company?s Phase 2 Covid-19 trial in South Africa. Publisher Grafa Following Author Grafa
